BioXcel and Centrexion Therapeutics Further Advance Big Data Innovation Lab Collaboration in Chronic Pain
October 19, 2016 08:00 ET
|
BioXcel Corporation
BRANFORD, Conn., Oct. 19, 2016 (GLOBE NEWSWIRE) -- BioXcel Corporation, a privately held biopharmaceutical company pioneering the integration of big data analytics and machine learning-based...
BioXcel Appoints Dr. Peter Mueller as Chairman of Scientific Advisory Board
October 12, 2016 08:00 ET
|
BioXcel Corporation
BRANFORD, Conn., Oct. 12, 2016 (GLOBE NEWSWIRE) -- BioXcel, a privately held biopharmaceutical company based in Connecticut, today announced the appointment of Dr. Peter Mueller, Ph.D. as Chairman...
BioXcel’s BXCL101, Receives Orphan Drug Designation from the U.S. FDA for the Treatment of Patients with Neurofibromatosis Type 2 (NF2)
September 13, 2016 09:00 ET
|
BioXcel Corporation
BRANFORD, Conn., Sept. 13, 2016 (GLOBE NEWSWIRE) -- BioXcel, a privately held biopharmaceutical company based in Connecticut, today announced that the U. S. Food and Drug Administration (FDA) has...
BioXcel Begins Strategic Collaboration with Alnylam to Discover Novel RNAi Therapeutic Products
May 24, 2016 12:30 ET
|
BioXcel Corporation
BRANFORD, Conn., May 24, 2016 (GLOBE NEWSWIRE) -- BioXcel Corporation, a global leader in real-time big data platforms for the discovery and development of transformative patient treatments, today...
BioXcel to Present at the 3rd International Conference on the Progress of Regenerative Medicine and its Cultural Impact at the Vatican
April 27, 2016 08:00 ET
|
BioXcel Corporation
BRANFORD, Conn., April 27, 2016 (GLOBE NEWSWIRE) -- BioXcel Corporation, a global leader in cloud-based big data platforms and developer of transformative patient treatments, today announced that...
BioXcel to Present at the 3rd International Conference on the Progress of Regenerative Medicine and its Cultural Impact at the Vatican
April 27, 2016 03:00 ET
|
BioXcel Corporation
BRANFORD, Conn., April 27, 2016 (GLOBE NEWSWIRE) -- BioXcel Corporation, a global leader in cloud-based big data platforms and developer of transformative patient treatments, today announced that...
BioXcel Celebrates 10th Anniversary as Leader of Big Data Revolution in Healthcare
February 18, 2016 19:30 ET
|
BioXcel Corporation
GURGAON, India, Feb. 18, 2016 (GLOBE NEWSWIRE) -- BioXcel Corporation, a global leader in cloud-based big data platforms and developer of transformative patient treatments, and its Gurgaon-based...
BioXcel Expands Into CNS Orphan Disease Therapeutics
February 08, 2016 08:30 ET
|
BioXcel Corporation
BRANFORD, Conn., Feb. 08, 2016 (GLOBE NEWSWIRE) -- BioXcel Corporation, a global leader in cloud-based big data platforms and developer of transformative patient treatments, today announced its...
BioXcel Strengthens Position in Immuno-Oncology With Dedicated Big Data Analytics Platform
January 21, 2016 08:30 ET
|
BioXcel Corporation
BRANFORD, Conn., Jan. 21, 2016 (GLOBE NEWSWIRE) -- BioXcel Corporation, a global leader in cloud-based big data platforms and developer of transformative patient treatments, today announced the...
BioXcel and Centrexion Partner to Develop Novel Chronic Pain Therapies
January 11, 2016 08:00 ET
|
BioXcel Corporation
BRANFORD, Conn., Jan. 11, 2016 (GLOBE NEWSWIRE) -- BioXcel Corporation, a global leader in developing cloud-based big data platforms and transformative patient treatments, today announced a...